SOM Biotech SL
We discover, develop, patent and license new indications of drugs. 1 product licensed in US, 1 product in Phase 2a, 20 new projects and 3 co-developments.
Founded in 2009, SOM develops new applications of already know drugs, by using mainly its proprietary in-silico platform. We file international patents and develop the compound to clinical proof of concept. Repurposing drugs is going to be a business of more than $30Bill sales in 2020. Our business model is based on up-front, milestones and royalty payments. One product has being licensed to a US company and another one is starting Phase 2.